ArticleGlobal journal of health science2014

Cost-effectiveness analysis of trastuzumab in the adjuvant treatment for early breast cancer.

Ali Aboutorabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.